Hepatitis A Virus Cellular Receptor 2 Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2029

Hepatitis A Virus Cellular Receptor 2 Market is anticipated to grow at a significant CAGR during the forecast period. Hepatitis A virus cellular receptor 2 (HAVCR2) is also known as T-cell immunoglobulin and mucin-domain containing-3 (TIM-3). It is a protein that is encoded by the HAVCR2 (TIM-3)gene in humans. The major factor driving the demand for the global hepatitis A virus cellular receptor 2 market is the increasing prevalence of colon cancer across the globe.

According to the American Society of Clinical Oncology (ASCO), in 2022, colorectal cancer is the third most diagnosed cancer globally with an estimated 151,030 adults will be diagnosed with colorectal cancer in the US. Additionally, it includes 106,180 new cases of colon cancer including 54,040 cases in men and 52,140 cases in women and 44,850 new cases of rectal cancer with 26,650 in men and 18,200 in women. Furthermore, an estimated 1,880,725 people were diagnosed with colorectal cancer in 2020 which include 1,148,515 colon cancer cases and 732,210 rectal cancer cases.

Apart from this TIM-3 plays an important role in inhibiting T cell responses in both autoimmunity and cancer. Additionally, it interacts with the PD-1 pathway in the dysfunctional CD8+ T cells and Tregs in cancer. Hence, the increasing prevalence of cancer is driving the growth of the global hepatitis A virus cellular receptor 2 market during the forecast period. Moreover, North America is anticipated to hold a prominent share in the market owing to the significant prevalence of diseases such as cancer, and acute myeloid leukemia (AML), among others. Some major players in the market include BeiGene Ltd., Eli Lilly and Co., Novartis International AG, among others.

To Request a Sample of our Report on Hepatitis A Virus Cellular Receptor 2 Market: https://www.omrglobal.com/request-sample/hepatitis-a-virus-cellular-receptor-2-market

Market Coverage

· The market number available for - 2022-2030

· Base year- 2022

· Forecast period- 2023-2030

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape-BeiGene Ltd., Eli Lilly and Co., and Novartis International AG, among others.

Hepatitis A Virus Cellular Receptor 2 Market Report by Segment

By Type

• IMM-1802

• LY-3321367

• MCLA-134

• CA-170

• CA-327

• ENUM-005

• Others

By Application

• Colon Cancer

• Myelodysplastic

• Non-Small Cell Lung Cancer

A full Report of Hepatitis A Virus Cellular Receptor 2 Market is Available @ https://www.omrglobal.com/industry-reports/hepatitis-a-virus-cellular-receptor-2-market

Hepatitis A Virus Cellular Receptor 2 Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.